Anti-ADAM17 Reference Antibody (Cancer Research Tech patent anti-ADAM17), IgG1, Monoclonal

Produktübersicht

• Artikelname: Anti-ADAM17 Reference Antibody (Cancer Research Tech patent anti-ADAM17), IgG1, Monoclonal
• Artikelnummer: SYB-CHB912
• Hersteller Artikelnummer: CHB912
• Alternativnummer: SYB-CHB912-100UG, SYB-CHB912-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics

Produktbeschreibung

Anti-ADAM17 Reference Antibody (Cancer Research Tech patent anti-ADAM17)(CHB912) is expressed from CHO. The heavy chain type is IgG1, and the light chain type is kappa. It has a predicted MW of 144.74 kDa.

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 1mg/ml
• Isotyp: IgG1
• UniProt: P78536
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Reinheit: >95%
• Formulierung: Lyophilize
• Target-Kategorie: ADAM17